{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:58:02Z","timestamp":1782593882765,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T00:00:00Z","timestamp":1617148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Psoriasis is a chronic inflammatory skin condition commonly associated with psoriatic arthritis, malignancy, diabetes, inflammatory bowel disease, and cardiovascular disease. Several reports and studies have reported an association between psoriasis and non-ischemic dilated cardiomyopathy (NIDCM). We aim to study the relationship between psoriasis and non-ischemic dilated cardiomyopathy in a large population-based study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We utilized the Healthcare Cost and Utilization Project National Inpatient Sample 2017 database, which represents a 20% sample of all payer hospitalizations in the United States. We investigated hospitalizations for patients aged 18\u00a0years old or older with diagnoses of any type of psoriasis and non-ischemic dilated cardiomyopathy. Psoriasis, cardiomyopathy, and other comorbidities were identified through their international classification of diseases, 10th revision codes recorded in the discharge record for each hospitalization.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Of a total of 6,084,184 all-cause admissions, 0.5% were admissions for patients with psoriasis (n\u2009=\u200932,807). Of the patients with and without psoriasis who had non-ischemic dilated cardiomyopathy, after adjusting for age, sex, race, diabetes mellitus, hypertension, alcohol abuse, cocaine abuse, arrhythmias, and obesity in a multivariate analysis, the presence of psoriasis was not significantly associated with non-ischemic dilated cardiomyopathy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Psoriasis is a chronic autoimmune disorder which carries a higher cardiovascular events and more prevalent traditional atherosclerotic risk factors in comparison to the general population. However, association with non-ischemic cardiomyopathy or NIDCM in particular has not been studied sufficiently. Our study, being one of the first larger studies to assess this correlation, indicated no relationship between psoriasis and non-ischemic dilated cardiomyopathy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-021-01972-0","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T18:03:13Z","timestamp":1617213793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Psoriasis as risk factor for non-ischemic dilated cardiomyopathy: a population-based cross-sectional study"],"prefix":"10.1186","volume":"21","author":[{"given":"Abbas","family":"Alshami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasam","family":"Alfraji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Douedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapnil","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Alpert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Calderon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,31]]},"reference":[{"issue":"2","key":"1972_CR1","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/jdv.13854","volume":"31","author":"IM Michalek","year":"2017","unstructured":"Michalek IM, Loring B, John SM. A systematic review of worldwide epidemiology of psoriasis. J Eur Acad Dermatol Venereol. 2017;31(2):205\u201312. https:\/\/doi.org\/10.1111\/jdv.13854.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"1972_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/diseases6020047","volume":"6","author":"F Benhadou","year":"2018","unstructured":"Benhadou F, Mintoff D, Schnebert B, Thio HB. Psoriasis and microbiota: a systematic review. Diseases. 2018;6(2):47. https:\/\/doi.org\/10.3390\/diseases6020047.","journal-title":"Diseases"},{"issue":"6","key":"1972_CR3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/09546630902817887","volume":"20","author":"SL Taylor","year":"2009","unstructured":"Taylor SL, Petrie M, O\u2019Rourke KS, Feldman SR. Rheumatologists\u2019 recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients\u2019 joint symptoms. J Dermatol Treat. 2009;20(6):350\u20133. https:\/\/doi.org\/10.3109\/09546630902817887.","journal-title":"J Dermatolog Treat"},{"issue":"5\u20136","key":"1972_CR4","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1080\/09546630500335977","volume":"16","author":"DJ Pearce","year":"2005","unstructured":"Pearce DJ, Morrison AE, Higgins KB, Crane MM, Balkrishnan R, Fleischer AB Jr, Feldman SR. The comorbid state of psoriasis patients in a university dermatology practice. J Dermatol Treat. 2005;16(5\u20136):319\u201323. https:\/\/doi.org\/10.1080\/09546630500335977.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"1972_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semarthrit.2006.09.001","volume":"36","author":"O Kimhi","year":"2007","unstructured":"Kimhi O, Caspi D, Bornstein N, Maharshak N, Gur A, et al. Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis. Semin Arthritis Rheum. 2007;36(4):203\u20139. https:\/\/doi.org\/10.1016\/j.semarthrit.2006.09.001.","journal-title":"Semin Arthritis Rheum"},{"key":"1972_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000121333","volume":"217","author":"AB Kimball","year":"2008","unstructured":"Kimball AB, Robinson D Jr, Wu Y, Guzzo C, Yeilding N, Paramore C, Fraeman K, Bala M. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001\u20132002. Dermatology. 2008;217:27\u201337. https:\/\/doi.org\/10.1159\/000121333.","journal-title":"Dermatology"},{"key":"1972_CR7","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1136\/ard.2008.094839","volume":"68","author":"DD Gladman","year":"2009","unstructured":"Gladman DD, Ang M, Su L, et al. Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis. 2009;68:1131\u20135. https:\/\/doi.org\/10.1136\/ard.2008.094839.","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"1972_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/annrheumdis-2014-206824","volume":"75","author":"AM Gulati","year":"2016","unstructured":"Gulati AM, Semb AG, Rollefstad S, et al. On the HUNT for cardiovascular risk factors and disease in patients with psoriatic arthritis: population-based data from the Nord\u2013Tr\u00f8ndelag health study. Ann Rheum Dis. 2016;75(5):819\u201324. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206824.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1972_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s10067-014-2743-7","volume":"33","author":"M Khraishi","year":"2014","unstructured":"Khraishi M, Aslanov R, Rampakakis E, Pollock C, Sampalis JS. Prevalence of cardiovascular risk factors in patients with psoriatic arthritis. Clin Rheumatol. 2014;33(10):1495\u2013500. https:\/\/doi.org\/10.1007\/s10067-014-2743-7.","journal-title":"Clin Rheumatol"},{"key":"1972_CR10","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/annrheumdis-2014-205675","volume":"74","author":"A Ogdie","year":"2015","unstructured":"Ogdie A, Yu Y, Haynes K, et al. Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis. 2015;74:326\u201332. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205675.","journal-title":"Ann Rheum Dis"},{"key":"1972_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/annrheumdis-2014-206617","volume":"74","author":"SL Kristensen","year":"2015","unstructured":"Kristensen SL, McInnes IB, Sattar N. Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation? Ann Rheum Dis. 2015;74:321\u20132. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206617.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1972_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00296-016-3487-2","volume":"37","author":"KM Yim","year":"2017","unstructured":"Yim KM, Armstrong AW. Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms. Rheumatol Int. 2017;37(1):97\u2013105. https:\/\/doi.org\/10.1007\/s00296-016-3487-2.","journal-title":"Rheumatol Int"},{"key":"1972_CR13","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1007\/s10067-019-04528-y","volume":"38","author":"A Kibari","year":"2019","unstructured":"Kibari A, Cohen AD, Gazitt T, et al. Cardiac and cardiovascular morbidities in patients with psoriatic arthritis: a population-based case control study. Clin Rheumatol. 2019;38:2069\u201375. https:\/\/doi.org\/10.1007\/s10067-019-04528-y.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"1972_CR14","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1590\/abd1806-4841.20142874","volume":"89","author":"I Baeta","year":"2014","unstructured":"Baeta I, Bittencourt F, Gontijo B, et al. Comorbidities and cardiovascular risk factors in patients with psoriasis. An Bras Dermatol. 2014;89(5):735\u201344. https:\/\/doi.org\/10.1590\/abd1806-4841.20142874.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"1972_CR15","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000121605","volume":"111","author":"N Eliakim-Raz","year":"2008","unstructured":"Eliakim-Raz N, Shuvy M, Lotan C, Planer D. Psoriasis and dilated cardiomyopathy: coincidence or associated diseases? Cardiology. 2008;111(3):202\u20136. https:\/\/doi.org\/10.1159\/000121605.","journal-title":"Cardiology"},{"issue":"01","key":"1972_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.21474\/IJAR01\/10335","volume":"8","author":"B Abdelaoui","year":"2020","unstructured":"Abdelaoui B, Benlafkih O, Ztati M, Karimi S, et al. The diagnosis of dilated cardiomyopathy during extended psoriasis: case report. Int J Adv Res. 2020;8(01):596\u2013600. https:\/\/doi.org\/10.21474\/IJAR01\/10335.","journal-title":"Int J Adv Res"},{"key":"1972_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/dth.12021","volume":"26","author":"A Pietrzak","year":"2013","unstructured":"Pietrzak A, Brzozowska A, Lotti T, Mosiewicz J, Wysoki\u0144ski A, et al. Psoriasis and cardiovascular. Dermatol Ther. 2013;26:489\u201392. https:\/\/doi.org\/10.1111\/dth.12021.","journal-title":"Dermatol Ther"},{"key":"1972_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1046\/j.1365-2133.1998.02085.x","volume":"138","author":"K Fukuhara","year":"1998","unstructured":"Fukuhara K, Urano Y, Akaike M, Ahsan K, Arase S. Psoriatic arthritis associated with dilated cardiomyopathy and Takayasu\u2019s arteritis. Br J Dermatol. 1998;138:329\u201333. https:\/\/doi.org\/10.1046\/j.1365-2133.1998.02085.x.","journal-title":"Br J Dermatol"},{"key":"1972_CR19","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/jdv.12123","volume":"28","author":"C-T Zhao","year":"2014","unstructured":"Zhao C-T, Yeung C-K, Siu C-W, Tam S, Chan J, Chen Y, Chan H-H, Tse H-F, Yiu K-H. Relationship between parathyroid hormone and subclinical myocardial dysfunction in patients with severe psoriasis. J Eur Acad Dermatol Venereol. 2014;28:461\u20138. https:\/\/doi.org\/10.1111\/jdv.12123.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"1972_CR20","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s00403-015-1586-7","volume":"307","author":"S Milaniuk","year":"2015","unstructured":"Milaniuk S, Pietrzak A, Mosiewicz B, Mosiewicz J, Reich K. Influence of psoriasis on circulatory system function assessed in echocardiography. Arch Dermtol Res. 2015;307(10):855\u201361. https:\/\/doi.org\/10.1007\/s00403-015-1586-7.","journal-title":"Arch Dermtol Res"},{"issue":"6","key":"1972_CR21","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1177\/147323000603400608","volume":"34","author":"I Biyik","year":"2006","unstructured":"Biyik I, Narin A, Bozok M, Ergene O. Echocardiographic and clinical abnormalities in patients with psoriasis. J Int Med Res. 2006;34(6):632\u20139. https:\/\/doi.org\/10.1177\/147323000603400608.","journal-title":"J Int Med Res"},{"issue":"2","key":"1972_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.14423\/SMJ.0000000000000603","volume":"110","author":"T Hashim","year":"2017","unstructured":"Hashim T, Ahmad A, Chaudry A, Khouzam R. Psoriasis and cardiomyopathy: a review of the literature. South Med J. 2017;110(2):97\u2013100. https:\/\/doi.org\/10.14423\/SMJ.0000000000000603.","journal-title":"South Med J"},{"issue":"4","key":"1972_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.autrev.2018.12.005","volume":"18","author":"VA Ryabkova","year":"2019","unstructured":"Ryabkova VA, Shubik YV, Erman MV, Churilov LP, Kanduc D, Shoenfeld Y. Lethal immunoglobulins: autoantibodies and sudden cardiac death. Autoimmun Rev. 2019;18(4):415\u201325. https:\/\/doi.org\/10.1016\/j.autrev.2018.12.005.","journal-title":"Autoimmun Rev"},{"key":"1972_CR24","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/247553031600100206","volume":"1","author":"L Prussick","year":"2016","unstructured":"Prussick L, Jimenez E, Nussbaum D, Prussick R. Psoriasis and psychological comorbidities. J Psoriasis Psoriatic Arthritis. 2016;1:80\u20135. https:\/\/doi.org\/10.1177\/247553031600100206.","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"1972_CR25","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/PTT.S164104","volume":"9","author":"C Svanstr\u00f6m","year":"2019","unstructured":"Svanstr\u00f6m C, Lonne-Rahm SB, Nordlind K. Psoriasis and alcohol. Psoriasis. 2019;9:75\u20139. https:\/\/doi.org\/10.2147\/PTT.S164104.","journal-title":"Psoriasis"},{"issue":"2","key":"1972_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/ajd.12895","volume":"60","author":"M Rademaker","year":"2019","unstructured":"Rademaker M, Agnew K, Anagnostou N, et al. Psoriasis and infection. A clinical practice narrative. Australas J Dermatol. 2019;60(2):91\u20138. https:\/\/doi.org\/10.1111\/ajd.12895.","journal-title":"Australas J Dermatol."}],"updated-by":[{"DOI":"10.1186\/s12872-021-01984-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000}}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01972-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-021-01972-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-021-01972-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,31]],"date-time":"2021-07-31T01:42:36Z","timestamp":1627695756000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-021-01972-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,31]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1972"],"URL":"https:\/\/doi.org\/10.1186\/s12872-021-01972-0","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,31]]},"assertion":[{"value":"6 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12872-021-01984-w","URL":"https:\/\/doi.org\/10.1186\/s12872-021-01984-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Institutional review board (IRB) is not required to for studies utilizing the national inpatient sample, as it falls under the \u201climited data sets\u201d category exempted by the HIPAA privacy regulations (). The study was conducted in agreement with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}